Report Detail
Global Atrophic Vaginitis Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4742377 |
- 28 September, 2026 |
- Global |
- 98 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Atrophic Vaginitis Treatment market size was valued at US$ 3281 million in 2025 and is forecast to a readjusted size of US$ 5524 million by 2032 with a CAGR of 7.8% during review period.
Vaginal atrophy (also called atrophic vaginitis) is a condition where the lining of the vagina gets drier and thinner. This results in itching, burning and pain during sex, among other symptoms.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Atrophic Vaginitis Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Atrophic Vaginitis Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Atrophic Vaginitis Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Atrophic Vaginitis Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Atrophic Vaginitis Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Atrophic Vaginitis Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Atrophic Vaginitis Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shionogi, Duchesnay, Hormos Medical, Pantarhei Bioscience, Mithra Pharmaceuticals, AMAG Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc, Theramex, Endoceutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Atrophic Vaginitis Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vaginal Moisturizers
Water-based Lubricants
Market segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Major players covered
Shionogi
Duchesnay
Hormos Medical
Pantarhei Bioscience
Mithra Pharmaceuticals
AMAG Pharmaceuticals
Bayer HealthCare Pharmaceuticals Inc
Theramex
Endoceutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atrophic Vaginitis Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Atrophic Vaginitis Treatment, with price, sales quantity, revenue, and global market share of Atrophic Vaginitis Treatment from 2021 to 2026.
Chapter 3, the Atrophic Vaginitis Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atrophic Vaginitis Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Atrophic Vaginitis Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Atrophic Vaginitis Treatment.
Chapter 14 and 15, to describe Atrophic Vaginitis Treatment sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Atrophic Vaginitis Treatment Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Vaginal Moisturizers
- 1.3.3 Water-based Lubricants
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Atrophic Vaginitis Treatment Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital Pharmacy
- 1.4.3 Online Pharmacy
- 1.4.4 Retail Pharmacy
- 1.5 Global Atrophic Vaginitis Treatment Market Size & Forecast
- 1.5.1 Global Atrophic Vaginitis Treatment Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Atrophic Vaginitis Treatment Sales Quantity (2021-2032)
- 1.5.3 Global Atrophic Vaginitis Treatment Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Shionogi
- 2.1.1 Shionogi Details
- 2.1.2 Shionogi Major Business
- 2.1.3 Shionogi Atrophic Vaginitis Treatment Product and Services
- 2.1.4 Shionogi Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Shionogi Recent Developments/Updates
- 2.2 Duchesnay
- 2.2.1 Duchesnay Details
- 2.2.2 Duchesnay Major Business
- 2.2.3 Duchesnay Atrophic Vaginitis Treatment Product and Services
- 2.2.4 Duchesnay Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Duchesnay Recent Developments/Updates
- 2.3 Hormos Medical
- 2.3.1 Hormos Medical Details
- 2.3.2 Hormos Medical Major Business
- 2.3.3 Hormos Medical Atrophic Vaginitis Treatment Product and Services
- 2.3.4 Hormos Medical Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Hormos Medical Recent Developments/Updates
- 2.4 Pantarhei Bioscience
- 2.4.1 Pantarhei Bioscience Details
- 2.4.2 Pantarhei Bioscience Major Business
- 2.4.3 Pantarhei Bioscience Atrophic Vaginitis Treatment Product and Services
- 2.4.4 Pantarhei Bioscience Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Pantarhei Bioscience Recent Developments/Updates
- 2.5 Mithra Pharmaceuticals
- 2.5.1 Mithra Pharmaceuticals Details
- 2.5.2 Mithra Pharmaceuticals Major Business
- 2.5.3 Mithra Pharmaceuticals Atrophic Vaginitis Treatment Product and Services
- 2.5.4 Mithra Pharmaceuticals Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Mithra Pharmaceuticals Recent Developments/Updates
- 2.6 AMAG Pharmaceuticals
- 2.6.1 AMAG Pharmaceuticals Details
- 2.6.2 AMAG Pharmaceuticals Major Business
- 2.6.3 AMAG Pharmaceuticals Atrophic Vaginitis Treatment Product and Services
- 2.6.4 AMAG Pharmaceuticals Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 AMAG Pharmaceuticals Recent Developments/Updates
- 2.7 Bayer HealthCare Pharmaceuticals Inc
- 2.7.1 Bayer HealthCare Pharmaceuticals Inc Details
- 2.7.2 Bayer HealthCare Pharmaceuticals Inc Major Business
- 2.7.3 Bayer HealthCare Pharmaceuticals Inc Atrophic Vaginitis Treatment Product and Services
- 2.7.4 Bayer HealthCare Pharmaceuticals Inc Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Bayer HealthCare Pharmaceuticals Inc Recent Developments/Updates
- 2.8 Theramex
- 2.8.1 Theramex Details
- 2.8.2 Theramex Major Business
- 2.8.3 Theramex Atrophic Vaginitis Treatment Product and Services
- 2.8.4 Theramex Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Theramex Recent Developments/Updates
- 2.9 Endoceutics
- 2.9.1 Endoceutics Details
- 2.9.2 Endoceutics Major Business
- 2.9.3 Endoceutics Atrophic Vaginitis Treatment Product and Services
- 2.9.4 Endoceutics Atrophic Vaginitis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Endoceutics Recent Developments/Updates
3 Competitive Environment: Atrophic Vaginitis Treatment by Manufacturer
- 3.1 Global Atrophic Vaginitis Treatment Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Atrophic Vaginitis Treatment Revenue by Manufacturer (2021-2026)
- 3.3 Global Atrophic Vaginitis Treatment Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Atrophic Vaginitis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Atrophic Vaginitis Treatment Manufacturer Market Share in 2025
- 3.4.3 Top 6 Atrophic Vaginitis Treatment Manufacturer Market Share in 2025
- 3.5 Atrophic Vaginitis Treatment Market: Overall Company Footprint Analysis
- 3.5.1 Atrophic Vaginitis Treatment Market: Region Footprint
- 3.5.2 Atrophic Vaginitis Treatment Market: Company Product Type Footprint
- 3.5.3 Atrophic Vaginitis Treatment Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Atrophic Vaginitis Treatment Market Size by Region
- 4.1.1 Global Atrophic Vaginitis Treatment Sales Quantity by Region (2021-2032)
- 4.1.2 Global Atrophic Vaginitis Treatment Consumption Value by Region (2021-2032)
- 4.1.3 Global Atrophic Vaginitis Treatment Average Price by Region (2021-2032)
- 4.2 North America Atrophic Vaginitis Treatment Consumption Value (2021-2032)
- 4.3 Europe Atrophic Vaginitis Treatment Consumption Value (2021-2032)
- 4.4 Asia-Pacific Atrophic Vaginitis Treatment Consumption Value (2021-2032)
- 4.5 South America Atrophic Vaginitis Treatment Consumption Value (2021-2032)
- 4.6 Middle East & Africa Atrophic Vaginitis Treatment Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Atrophic Vaginitis Treatment Sales Quantity by Type (2021-2032)
- 5.2 Global Atrophic Vaginitis Treatment Consumption Value by Type (2021-2032)
- 5.3 Global Atrophic Vaginitis Treatment Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Atrophic Vaginitis Treatment Sales Quantity by Application (2021-2032)
- 6.2 Global Atrophic Vaginitis Treatment Consumption Value by Application (2021-2032)
- 6.3 Global Atrophic Vaginitis Treatment Average Price by Application (2021-2032)
7 North America
- 7.1 North America Atrophic Vaginitis Treatment Sales Quantity by Type (2021-2032)
- 7.2 North America Atrophic Vaginitis Treatment Sales Quantity by Application (2021-2032)
- 7.3 North America Atrophic Vaginitis Treatment Market Size by Country
- 7.3.1 North America Atrophic Vaginitis Treatment Sales Quantity by Country (2021-2032)
- 7.3.2 North America Atrophic Vaginitis Treatment Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Atrophic Vaginitis Treatment Sales Quantity by Type (2021-2032)
- 8.2 Europe Atrophic Vaginitis Treatment Sales Quantity by Application (2021-2032)
- 8.3 Europe Atrophic Vaginitis Treatment Market Size by Country
- 8.3.1 Europe Atrophic Vaginitis Treatment Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Atrophic Vaginitis Treatment Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Atrophic Vaginitis Treatment Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Atrophic Vaginitis Treatment Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Atrophic Vaginitis Treatment Market Size by Region
- 9.3.1 Asia-Pacific Atrophic Vaginitis Treatment Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Atrophic Vaginitis Treatment Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Atrophic Vaginitis Treatment Sales Quantity by Type (2021-2032)
- 10.2 South America Atrophic Vaginitis Treatment Sales Quantity by Application (2021-2032)
- 10.3 South America Atrophic Vaginitis Treatment Market Size by Country
- 10.3.1 South America Atrophic Vaginitis Treatment Sales Quantity by Country (2021-2032)
- 10.3.2 South America Atrophic Vaginitis Treatment Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Atrophic Vaginitis Treatment Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Atrophic Vaginitis Treatment Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Atrophic Vaginitis Treatment Market Size by Country
- 11.3.1 Middle East & Africa Atrophic Vaginitis Treatment Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Atrophic Vaginitis Treatment Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Atrophic Vaginitis Treatment Market Drivers
- 12.2 Atrophic Vaginitis Treatment Market Restraints
- 12.3 Atrophic Vaginitis Treatment Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Atrophic Vaginitis Treatment and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Atrophic Vaginitis Treatment
- 13.3 Atrophic Vaginitis Treatment Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Atrophic Vaginitis Treatment Typical Distributors
- 14.3 Atrophic Vaginitis Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Atrophic Vaginitis Treatment. Industry analysis & Market Report on Atrophic Vaginitis Treatment is a syndicated market report, published as Global Atrophic Vaginitis Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Atrophic Vaginitis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
